Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Novel Drug Delivery Systems Industry Compare Between 2025 And 2029?
The novel drug delivery systems market size has experienced rapid expansion in recent years. It is forecast to grow from $106.95 billion in 2024 to $117.66 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.0%. The historical growth of this market can be attributed to the rising prevalence of chronic diseases, an increasing geriatric population, the growing demand for minimally invasive therapies, heightened patient awareness regarding drug efficacy and safety, and the expansion of global healthcare infrastructure.
The novel drug delivery systems market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $171.02 billion by 2029, driven by a compound annual growth rate (CAGR) of 9.8%. This anticipated increase during the forecast period stems from a heightened global emphasis on pandemic readiness, a growing need for swift and localized drug administration, increased recognition of antimicrobial stewardship, stricter environmental and packaging rules promoting controlled delivery methods, and an uptick in public-private collaborations for pharmaceutical innovation. Significant developments expected within this period encompass the incorporation of nanocarriers and nanoemulsions, the creation of biodegradable and stimuli-responsive substances, enhanced application of 3D printing for personalized dosage forms, advancements in transdermal and microneedle technologies, and the implementation of artificial intelligence in designing formulations.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25850&type=smp
What Are The Drivers Pushing New Developments In The Novel Drug Delivery Systems Market?
An increase in neurological disorder cases is anticipated to fuel expansion within the novel drug delivery systems market in the coming period. A neurological condition like stroke involves an abrupt loss of brain function, resulting from a disruption of blood flow to the brain, caused by either an obstruction (ischemic stroke) or a burst blood vessel (hemorrhagic stroke). This can cause brain tissue damage and potential enduring cognitive, sensory, or motor deficits. The growing occurrence of neurological disorders is chiefly attributed to an aging global populace, a rise in lifestyle-associated ailments including hypertension, diabetes, and obesity, along with greater exposure to chronic stress and environmental hazards. These novel drug delivery systems facilitate the management of neurological disorders by providing targeted and controlled therapeutic delivery past the blood-brain barrier. As an illustration, data from November 2024, provided by the National Health Service (NHS) England, a UK-based healthcare provider, indicated that stroke admissions in England climbed to 111,137 during 2023/24, with the 50–59 age group seeing the most significant rise, tallying 12,533 cases. Consequently, the increasing instances of neurological disorders are fueling the expansion of the novel drug delivery systems market.
How Is The Novel Drug Delivery Systems Market Classified Into Different Segments?
The novel drug delivery systems market covered in this report is segmented –
1) By Formulation Type: Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers
2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems
3) By Route: Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes
4) By Therapeutic Area: Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases
5) By End-User: Hospital, Specialty Clinics, Research Centers, Other End-Users
Subsegments:
1) By Liposomes: PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes
2) By Nanoparticles: Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals
3) By Microspheres: Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres
4) By Hydrogels: Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels
5) By Dendrimers: PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers
Which Ongoing Trends Are Expected To Shape The Novel Drug Delivery Systems Market Outlook?
Leading companies in the novel drug delivery systems market are focused on developing innovative solutions, like oral thin films, to improve patient adherence and therapeutic efficacy. An oral thin film is a drug delivery method comprising a rapidly dissolving film strip applied inside the oral cavity, designed to release medication directly into the bloodstream through the mucosal lining. For instance, in February 2024, CD Formulation, a US-based pharmaceutical formulation company, launched Oral Thin Film Technology. This product enables swift drug absorption by bypassing gastrointestinal and liver metabolism, making it especially suitable for patients facing swallowing difficulties. It also supports accurate dosing and a faster onset of action, thereby enhancing treatment precision and convenience across various therapeutic applications.
Who Are The Primary Competitors In The Global Novel Drug Delivery Systems Market?
Major companies operating in the novel drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Thermo Fisher Scientific Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC (GSK), Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/novel-drug-delivery-systems-global-market-report
What Are The Key Regional Factors Influencing The Novel Drug Delivery Systems Market Growth?
North America was the largest region in the novel drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Novel Drug Delivery Systems Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25850&type=smp
Browse Through More Reports Similar to the Global Novel Drug Delivery Systems Market 2025, By The Business Research Company
Advanced Drug Delivery Systems Global Market Report 2025
Electronic Drug Delivery Systems Global Market Report 2025
Pharmaceutical Drug Delivery Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model